Send to

Choose Destination
Int J Appl Basic Med Res. 2013 Jul;3(2):75-6. doi: 10.4103/2229-516X.117047.

Will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance?

Author information

Cardiometabolic Research Institute, Houston, Texas, USA.

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center